FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1566993644> ?p ?o ?g. }

• W1566993644 abstract "Despite the approval of the anti-epidermal growth factor receptor (EGFR) monoclonal antibodies (mAbs) cetuximab and panitumumab for the treatment of colorectal cancer patients, there is currently no reliable predictive marker for response to therapy. EGFR is the prototype of human epidermal growth factor receptor (HER) family, which includes three additional members namely HER-2, HER-3 and HER-4. The aim of this study was to investigate the sensitivity of a panel of human colorectal cancer cell lines to treatment with afatinib, an irreversible pan-HER blocker, the EGFR tyrosine kinase inhibitors (TKls) gefitinib and erlotinib, anti-EGFR mAb ICR62 and cytotoxic drugs and to determine whether there was any association between the expression levels of HER family members, the putative cancer stem cell (CSC) markers CD44 and CD133 and ABC transporters (e.g. p-glycoprotein) and response to these agents. The expression pattern and clinical significance of these markers in tumour specimens from 86 Dukes' C and D colorectal cancer patients was determined.Overexpression of the HER family members were found to be uncommon in this panel of human colorectal cancer cell lines, except for EGFR overexpression in DiFi cells. Of the HER inhibitors, afatinib was the most effective agent for inhibiting the growth in vitro of human colorectal cancer cell lines and the expression of HER -4 alone and the co-expression of all the HER family members were associated with response to treatment with afatinib. Acquired resistance of the EGFR overexpressing colorectal cancer cells to treatment with afatinib, ICR62 or gefitinib was accompanied by the up-regulation of EGFR. However, tumour cells that acquired resistance to anti-EGFR mAb ICR62 remained sensitive to treatment with afatinib and vice versa, suggesting that mechanisms underlying the antitumor activity of ICR62 and afatinib are different. The expression ofEGFR, HER-2, HER-3, HER-4 and co-expression of all the HER family members was found in 42.5%, 77%, 52%, 91 % and 18% of the tumour specimens from 86 Dukes' C and D colorectal cancer patients respectively. While all the patients expressed COX-2 and Ki-67, the expression ofCD44 and CD133 was found in 58.6% and 81.9% of the cases, respectively. The expression of EGFR and low expression of Ki-67 were found to be significantly associated with poor disease free survival. The co-expression of HER family members in colorectal cancer patients provides a rationale for investigating the pattern, prognostic significance and predictive value of the HER family members for response to therapy with anti-EGFR mAbs. Further investigations in vivo on the therapeutic potential of pan-HER blockers, such as afatinib, in colorectal cancer patients whose tumours co-express more than one member of the HER family should also be considered." @default.
• W1566993644 created "2016-06-24" @default.
• W1566993644 creator A5077687711 @default.
• W1566993644 date "2012-12-01" @default.
• W1566993644 modified "2023-09-23" @default.
• W1566993644 title "The biological and clinical significance of HER family members and cancer stem cells in colorectal cancer and response to therapeutic interventions" @default.
• W1566993644 hasPublicationYear "2012" @default.
• W1566993644 type Work @default.
• W1566993644 sameAs 1566993644 @default.
• W1566993644 citedByCount "0" @default.
• W1566993644 crossrefType "dissertation" @default.
• W1566993644 hasAuthorship W1566993644A5077687711 @default.
• W1566993644 hasConcept C121608353 @default.
• W1566993644 hasConcept C126322002 @default.
• W1566993644 hasConcept C143998085 @default.
• W1566993644 hasConcept C1491633281 @default.
• W1566993644 hasConcept C2777506169 @default.
• W1566993644 hasConcept C2778087573 @default.
• W1566993644 hasConcept C2778332735 @default.
• W1566993644 hasConcept C2779438470 @default.
• W1566993644 hasConcept C2779998722 @default.
• W1566993644 hasConcept C2780580887 @default.
• W1566993644 hasConcept C2780586478 @default.
• W1566993644 hasConcept C2780932548 @default.
• W1566993644 hasConcept C502942594 @default.
• W1566993644 hasConcept C526805850 @default.
• W1566993644 hasConcept C54355233 @default.
• W1566993644 hasConcept C55427017 @default.
• W1566993644 hasConcept C71924100 @default.
• W1566993644 hasConcept C86803240 @default.
• W1566993644 hasConceptScore W1566993644C121608353 @default.
• W1566993644 hasConceptScore W1566993644C126322002 @default.
• W1566993644 hasConceptScore W1566993644C143998085 @default.
• W1566993644 hasConceptScore W1566993644C1491633281 @default.
• W1566993644 hasConceptScore W1566993644C2777506169 @default.
• W1566993644 hasConceptScore W1566993644C2778087573 @default.
• W1566993644 hasConceptScore W1566993644C2778332735 @default.
• W1566993644 hasConceptScore W1566993644C2779438470 @default.
• W1566993644 hasConceptScore W1566993644C2779998722 @default.
• W1566993644 hasConceptScore W1566993644C2780580887 @default.
• W1566993644 hasConceptScore W1566993644C2780586478 @default.
• W1566993644 hasConceptScore W1566993644C2780932548 @default.
• W1566993644 hasConceptScore W1566993644C502942594 @default.
• W1566993644 hasConceptScore W1566993644C526805850 @default.
• W1566993644 hasConceptScore W1566993644C54355233 @default.
• W1566993644 hasConceptScore W1566993644C55427017 @default.
• W1566993644 hasConceptScore W1566993644C71924100 @default.
• W1566993644 hasConceptScore W1566993644C86803240 @default.
• W1566993644 hasLocation W15669936441 @default.
• W1566993644 hasOpenAccess W1566993644 @default.
• W1566993644 hasPrimaryLocation W15669936441 @default.
• W1566993644 hasRelatedWork W1754797577 @default.
• W1566993644 hasRelatedWork W2002817170 @default.
• W1566993644 hasRelatedWork W2008914408 @default.
• W1566993644 hasRelatedWork W2017336826 @default.
• W1566993644 hasRelatedWork W2083527129 @default.
• W1566993644 hasRelatedWork W2111215507 @default.
• W1566993644 hasRelatedWork W2118902065 @default.
• W1566993644 hasRelatedWork W2146437683 @default.
• W1566993644 hasRelatedWork W2166429211 @default.
• W1566993644 hasRelatedWork W2293689405 @default.
• W1566993644 hasRelatedWork W2403079980 @default.
• W1566993644 hasRelatedWork W2479263109 @default.
• W1566993644 hasRelatedWork W2604626000 @default.
• W1566993644 hasRelatedWork W2790079100 @default.
• W1566993644 hasRelatedWork W2810781529 @default.
• W1566993644 hasRelatedWork W2888547689 @default.
• W1566993644 hasRelatedWork W2908755091 @default.
• W1566993644 hasRelatedWork W2954455050 @default.
• W1566993644 hasRelatedWork W3127763729 @default.
• W1566993644 hasRelatedWork W3180628252 @default.
• W1566993644 isParatext "false" @default.
• W1566993644 isRetracted "false" @default.
• W1566993644 magId "1566993644" @default.
• W1566993644 workType "dissertation" @default.